Terazosin Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Terazosin Terazosin EP Impurity C VL4370002View CAS 60547-97-9
Terazosin Terazosin EP Impurity D (free base ) VL4370001View CAS 102714-74-9
Terazosin Terazosin EP Impurity E VL4370006View CAS 1486464-41-8
Terazosin Terazosin EP Impurity E (free base) VL4370003View CAS 102839-00-9
Terazosin Terazosin EP Impurity H VE0011573View CAS 105356-90-9
Terazosin Terazosin EP Impurity L VL4370005View CAS 40172-95-0
Terazosin Terazosin EP Impurity M VL4370004View CAS 31350-27-3
Terazosin Terazosin EP Impurity N VE008306View CAS 63074-07-7
Terazosin Terazosin EP Impurity O VE006793View CAS 547730-06-3

Request a quote

102714-74-9: Terazosin EP Impurity D (free base )

102714-74-9: Terazosin EP Impurity D (free base )
Catalogue No.

VL4370001

CAS No.

102714-74-9

Molecular Formula

C15H19O3

Molecular Weight

317.34

Parent drug

Terazosin

IUPAC Name

4-(4-Amino-6, 7-dimethoxy-2-quinazolinyl)-1-piperazinecarboxaldehyde

Synonyms

N/A

References

Sci-Hub, The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia, 10.1056/nejm199608223350801. (2022). Retrieved January 25, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1056/nejm199608223350801 ?

Status

In-stock

ListName

Terazosin EP Impurity D (free base )

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url